Bioventix
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bioventix generated cash of $8,546,097, which is more than the previous year. Cash used in financing activities reached the amount of -$8,247,056 last year. Net change in cash is therefore $283,134.
Cash Flow
| 2011 | 766.13K | -10.73K | -572.84K |
|---|---|---|---|
| 2012 | 1.23M | -16.7K | -574.90K |
| 2016 | 3.17M | 2.57K | -1.92M |
| 2018 | 5.92M | -169.38K | -4.93M |
| 2020 | 7.72M | -561.28K | -5.62M |
| 2021 | 6.36M | -259.82K | -7.68M |
| 2023 | 7.90M | -10.58K | -8.30M |
| 2024 | 8.54M | -15.90K | -8.24M |
BVXP.L Cash Flow Statement (2011 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.71M | 6.12M | 8.07M | 6.53M | 6.16M | 4.13M | 1.53M | 1.34M |
Operating activities | ||||||||
Net income | 8.09M | 8.37M | 6.73M | 7.20M | 5.66M | 3.49M | 1.23M | 884.45K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 113.63K | 129.22K | 135.10K | 133.56K | 58.49K | 41.72K | 43.34K | 45.55K |
Stock-based compensation expense | 0 | 174.08K | 257.62K | 115.48K | 136.12K | 53.22K | 0 | 0 |
| Deferred income tax benefit | 0 | 174.08K | 257.62K | 115.48K | 136.12K | 53.22K | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | -394.67K | -626.55K | -976.59K | 284.54K | -509.73K | -594.90K | 0 | 0 |
Inventories | -49.97K | -103.55K | -87.03K | -6.12K | -56.91K | -5.96K | -14.94K | 19.43K |
Accounts payable | 83.01K | -52.61K | 59.51K | 133.97K | 27.23K | 19.55K | 0 | 0 |
Cash generated by operating activities | 8.54M | 7.90M | 6.36M | 7.72M | 5.92M | 3.17M | 1.23M | 766.13K |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | -221.66K | -95.86K | -43.33K | 0 | 0 |
Investments In Property Plant And Equipment | -15.90K | -10.58K | -260.32K | -339.62K | -107.59K | -21.01K | -16.7K | -10.73K |
Acquisitions Net | 0 | 0 | 500 | 0 | 250 | 0 | 0 | 0 |
Cash generated by investing activities | -15.90K | -10.58K | -259.82K | -561.28K | -169.38K | 2.57K | -16.7K | -10.73K |
Financing activities | ||||||||
Common Stock Issued | 0 | 139.36K | 20.22K | 879.67K | 0 | 0 | 0 | 0 |
Payments for dividends | -8.24M | -8.44M | -7.70M | -6.50M | -4.93M | -1.92M | -574.90K | -524.11K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -48.72K |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -8.24M | -8.30M | -7.68M | -5.62M | -4.93M | -1.92M | -574.90K | -572.84K |
Net Change In Cash | 283.13K | -410.83K | -1.58M | 1.53M | 819.57K | 1.24M | 647.49K | 182.56K |
Cash at end of period | 5.99M | 5.71M | 6.49M | 8.07M | 6.98M | 5.38M | 2.17M | 1.53M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |